- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
John C. Richter
Events 14 results
Webinar
November 9, 2021
King & Spalding Pharmaceutical University 2021
Webinar
November 10, 2020
13th Annual King & Spalding Medical Device Summit
Conference
November 12, 2019
12th Annual King & Spalding Pharmaceutical University
Speaking Engagement
November 6, 2019
John Richter, Richard Walker, Nikki Reeves to Speak at 20th Annual Pharmaceutical and Medical Device Compliance Congress
Conference
September 5, 2019
12th Annual Medical Device Summit
Speaking Engagement
July 22, 2019
John Richter to Chair Patient Services Compliance Summit
Conference
November 15, 2016
9th Annual King & Spalding Pharmaceutical University
Webinar
Conference
April 25, 2016
2016 Cybersecurity & Privacy Summit
Conference
April 7, 2016
West Coast Pharma & Medical Device University
Webinar
December 10, 2015
Criminal Punishment for Telling the Truth: Off-Label Promotion and the First Amendment
Conference
September 30, 2015
King & Spalding Medical Device Summit 2015